Fact CheckerSign in

NCT07793305Completed

Precision Diabetes Education Guided by Diabetes Complication Risk Assessment

Precision Diabetes Education According to Diabetic Complication Risk Assessment Tool

Source: ClinicalTrials.gov · Last updated 28 Aug 2026

Brief summary (registry, in English)

This prospective, multicenter interventional study evaluated the implementation of precision diabetes education guided by individualized diabetes complication risk assessment in adults with type 2 diabetes. The study was conducted at six hospitals in Taiwan. Participants underwent assessment of their predicted risks for six major diabetes-related complications: diabetic kidney disease, atherosclerotic cardiovascular disease, congestive heart failure, ischemic stroke, diabetic retinopathy, and lower-extremity amputation. Diabetes educators used the risk assessment results to identify the complication with the highest predicted risk and to provide individualized education focused on prevention and modification of relevant health behaviors. Participants continued to receive standard diabetes education and routine clinical care. Personalized education was provided at enrollment and again during follow-up, with clinical information, complication-risk assessment, and patient-reported measures collected during the 6-month study period. The study aimed to establish a personalized diabetes education model based on complication-risk assessment and to improve the quality of diabetes complication prevention and care.

Status (registry)
Completed
Study type
Interventional
Enrollment
180 (actual)
First submitted
25 Aug 2026
Start date
1 Mar 2024
Primary completion date
18 Feb 2025
Lead sponsor
Taiwanese Association of Diabetes Educators
NCT number
NCT07793305

What you commit to

  • Study type: Interventional
  • Participants enrolled: 180
  • From 1 Mar 2024 to the primary completion date, 18 Feb 2025
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Clinically unstable conditions, including acute diabetes-related conditions such as diabetic ketoacidosis, hyperosmolar hyperglycemic state, severe hypoglycemia, acute infection, or acute organ injury.
  • Terminal illness requiring palliative care or other conditions for which active treatment is no longer appropriate.

Other

  • Unwillingness or inability to provide written informed consent.

Who the study is looking for

  • Adults aged 18 years or older with a diagnosis of type 2 diabetes mellitus and without established chronic diabetes complications.
  • Hemoglobin A1c between 7% and 9%.
  • Stable type and dosage of glucose-lowering medications during the preceding 6 months.
  • Ability to independently understand the study information and procedures and to make an informed decision regarding participation.
  • Willingness to provide written informed consent.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kaohsiung Chang Gung Memorial Hospital
Coordinator of this site? Confirm its status
Kaohsiung CityTaiwanUnknown status
Kaohsiung Medical University Chung-Ho Memorial Hospital
Coordinator of this site? Confirm its status
Kaohsiung CityTaiwanUnknown status
Taichung Veterans General Hospital
Coordinator of this site? Confirm its status
TaichungTaiwanUnknown status
National Cheng Kung University Hospital
Coordinator of this site? Confirm its status
TainanTaiwanUnknown status
National Taiwan University Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanUnknown status
MacKay Memorial Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.